

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte development (GO:0003334) | 6.07948242 |
| 2 | melanin biosynthetic process (GO:0042438) | 6.00758623 |
| 3 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.42684360 |
| 4 | secondary metabolite biosynthetic process (GO:0044550) | 5.37344583 |
| 5 | protein K11-linked deubiquitination (GO:0035871) | 5.27557825 |
| 6 | melanin metabolic process (GO:0006582) | 5.20145575 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.19195438 |
| 8 | lactate metabolic process (GO:0006089) | 5.04622481 |
| 9 | proteasome assembly (GO:0043248) | 4.30668911 |
| 10 | platelet dense granule organization (GO:0060155) | 4.28815027 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24393341 |
| 12 | response to peptidoglycan (GO:0032494) | 4.14304535 |
| 13 | negative regulation of JUN kinase activity (GO:0043508) | 4.00840270 |
| 14 | neutrophil activation (GO:0042119) | 3.97937721 |
| 15 | negative regulation of neurological system process (GO:0031645) | 3.91701237 |
| 16 | granulocyte activation (GO:0036230) | 3.88430559 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.88128970 |
| 18 | DNA double-strand break processing (GO:0000729) | 3.86399237 |
| 19 | superoxide anion generation (GO:0042554) | 3.84754976 |
| 20 | negative regulation of dendrite development (GO:2000171) | 3.79748553 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70327248 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.70327248 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70327248 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.70327248 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70327248 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70327248 |
| 27 | melanosome organization (GO:0032438) | 3.68862296 |
| 28 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.63513796 |
| 29 | cullin deneddylation (GO:0010388) | 3.53877034 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.49570177 |
| 31 | myeloid dendritic cell activation (GO:0001773) | 3.42441255 |
| 32 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.41991760 |
| 33 | respiratory burst (GO:0045730) | 3.39364190 |
| 34 | myeloid dendritic cell differentiation (GO:0043011) | 3.35769912 |
| 35 | pigment granule organization (GO:0048753) | 3.35432284 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.34725802 |
| 37 | regulation of sulfur metabolic process (GO:0042762) | 3.33124739 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32760239 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.32760239 |
| 40 | regulation of Rac protein signal transduction (GO:0035020) | 3.28674694 |
| 41 | DNA deamination (GO:0045006) | 3.28259359 |
| 42 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28251888 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27670001 |
| 44 | signal peptide processing (GO:0006465) | 3.26765849 |
| 45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.25534265 |
| 46 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.25302531 |
| 47 | actin nucleation (GO:0045010) | 3.24975894 |
| 48 | regulation of hexokinase activity (GO:1903299) | 3.24755079 |
| 49 | regulation of glucokinase activity (GO:0033131) | 3.24755079 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.24166289 |
| 51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24055475 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21663638 |
| 53 | female gonad development (GO:0008585) | 3.21108696 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.18152965 |
| 55 | protein K6-linked ubiquitination (GO:0085020) | 3.17119712 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.16512854 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.16198551 |
| 58 | protein deneddylation (GO:0000338) | 3.16151223 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.15886235 |
| 60 | amine catabolic process (GO:0009310) | 3.15886235 |
| 61 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.15664601 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.15664601 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.15664601 |
| 64 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.13434875 |
| 65 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.13434875 |
| 66 | response to pheromone (GO:0019236) | 3.10150242 |
| 67 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09737979 |
| 68 | inositol phosphate catabolic process (GO:0071545) | 3.08088470 |
| 69 | nephron tubule formation (GO:0072079) | 3.05370078 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05311601 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.04011876 |
| 72 | negative regulation of protein autophosphorylation (GO:0031953) | 3.02995883 |
| 73 | polyol catabolic process (GO:0046174) | 3.00917989 |
| 74 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.99812173 |
| 75 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.99750783 |
| 76 | positive regulation of macrophage differentiation (GO:0045651) | 2.98552349 |
| 77 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.96720873 |
| 78 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.96720873 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96619247 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 2.96088438 |
| 81 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.95058056 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.94809452 |
| 83 | dendritic cell differentiation (GO:0097028) | 2.94139621 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 2.93979554 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 2.93679711 |
| 86 | respiratory chain complex IV assembly (GO:0008535) | 2.91512950 |
| 87 | regulation of DNA endoreduplication (GO:0032875) | 2.90381214 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 2.89158565 |
| 89 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.88659341 |
| 90 | microglial cell activation (GO:0001774) | 2.86712698 |
| 91 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.86365608 |
| 92 | reactive oxygen species biosynthetic process (GO:1903409) | 2.86270428 |
| 93 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.86152017 |
| 94 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85092630 |
| 95 | monocyte chemotaxis (GO:0002548) | 2.84518039 |
| 96 | hepatocyte apoptotic process (GO:0097284) | 2.84264265 |
| 97 | negative regulation of interleukin-17 production (GO:0032700) | 2.82962303 |
| 98 | histamine secretion (GO:0001821) | 2.82408419 |
| 99 | protein neddylation (GO:0045116) | 2.81908628 |
| 100 | ketone body metabolic process (GO:1902224) | 2.81346316 |
| 101 | isotype switching (GO:0045190) | 2.80892607 |
| 102 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.80892607 |
| 103 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.80892607 |
| 104 | myeloid leukocyte activation (GO:0002274) | 2.80464526 |
| 105 | regulation of interferon-alpha production (GO:0032647) | 2.80461358 |
| 106 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.80149669 |
| 107 | limb bud formation (GO:0060174) | 2.79631813 |
| 108 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79256475 |
| 109 | developmental pigmentation (GO:0048066) | 2.79190405 |
| 110 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.78592059 |
| 111 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.78359007 |
| 112 | inositol phosphate dephosphorylation (GO:0046855) | 2.78359007 |
| 113 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76162574 |
| 114 | leukocyte degranulation (GO:0043299) | 2.75859187 |
| 115 | replication fork processing (GO:0031297) | 2.75449741 |
| 116 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.75230370 |
| 117 | single strand break repair (GO:0000012) | 2.74852163 |
| 118 | germinal center formation (GO:0002467) | 2.73802958 |
| 119 | positive regulation of lymphocyte migration (GO:2000403) | 2.72924628 |
| 120 | positive regulation of interleukin-12 production (GO:0032735) | 2.72914947 |
| 121 | dendritic cell migration (GO:0036336) | 2.72019194 |
| 122 | sequestering of actin monomers (GO:0042989) | 2.71113874 |
| 123 | fucose catabolic process (GO:0019317) | 2.71009375 |
| 124 | L-fucose metabolic process (GO:0042354) | 2.71009375 |
| 125 | L-fucose catabolic process (GO:0042355) | 2.71009375 |
| 126 | membrane invagination (GO:0010324) | 2.70607432 |
| 127 | positive regulation of mast cell activation (GO:0033005) | 2.69149973 |
| 128 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.67731291 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.67462640 |
| 130 | mast cell activation (GO:0045576) | 2.67296892 |
| 131 | synapsis (GO:0007129) | 2.66202449 |
| 132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65246888 |
| 133 | blastocyst development (GO:0001824) | 2.64828524 |
| 134 | protein prenylation (GO:0018342) | 2.64818760 |
| 135 | prenylation (GO:0097354) | 2.64818760 |
| 136 | regulation of mast cell degranulation (GO:0043304) | 2.64798134 |
| 137 | negative regulation of viral genome replication (GO:0045071) | 2.63878620 |
| 138 | positive regulation of T cell migration (GO:2000406) | 2.62866971 |
| 139 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.61134121 |
| 140 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.60434757 |
| 141 | regulation of fever generation (GO:0031620) | 2.59446708 |
| 142 | regulation of cofactor metabolic process (GO:0051193) | 2.59029601 |
| 143 | regulation of coenzyme metabolic process (GO:0051196) | 2.59029601 |
| 144 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.58930981 |
| 145 | recombinational repair (GO:0000725) | 2.58207765 |
| 146 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.58162299 |
| 147 | B cell mediated immunity (GO:0019724) | 2.57855259 |
| 148 | regulation of mast cell activation (GO:0033003) | 2.57824149 |
| 149 | double-strand break repair via homologous recombination (GO:0000724) | 2.57430149 |
| 150 | phagocytosis, engulfment (GO:0006911) | 2.56163898 |
| 151 | dopamine transport (GO:0015872) | 2.55810936 |
| 152 | cellular response to interferon-beta (GO:0035458) | 2.55187901 |
| 153 | S-adenosylmethionine metabolic process (GO:0046500) | 2.54660557 |
| 154 | eosinophil chemotaxis (GO:0048245) | 2.54447035 |
| 155 | positive regulation of heat generation (GO:0031652) | 2.54376332 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54058348 |
| 157 | piRNA metabolic process (GO:0034587) | 2.53596931 |
| 158 | response to interferon-beta (GO:0035456) | 2.53104928 |
| 159 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50934757 |
| 160 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50642733 |
| 161 | leukocyte mediated cytotoxicity (GO:0001909) | 2.50295562 |
| 162 | type I interferon signaling pathway (GO:0060337) | 2.49789520 |
| 163 | cellular response to type I interferon (GO:0071357) | 2.49789520 |
| 164 | regulation of cellular extravasation (GO:0002691) | 2.48692811 |
| 165 | phenol-containing compound biosynthetic process (GO:0046189) | 2.47514344 |
| 166 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47282778 |
| 167 | negative regulation of phagocytosis (GO:0050765) | 2.47033034 |
| 168 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.46748585 |
| 169 | regulation of mononuclear cell migration (GO:0071675) | 2.45454529 |
| 170 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.44771829 |
| 171 | response to type I interferon (GO:0034340) | 2.44719401 |
| 172 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.44379534 |
| 173 | regulation of T cell chemotaxis (GO:0010819) | 2.44323800 |
| 174 | positive regulation of T cell chemotaxis (GO:0010820) | 2.44323800 |
| 175 | regulation of RIG-I signaling pathway (GO:0039535) | 2.43601205 |
| 176 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42776340 |
| 177 | response to host immune response (GO:0052572) | 2.42776340 |
| 178 | glial cell proliferation (GO:0014009) | 2.42353672 |
| 179 | macrophage activation (GO:0042116) | 2.42242756 |
| 180 | cytochrome complex assembly (GO:0017004) | 2.41846384 |
| 181 | positive regulation of cell size (GO:0045793) | 2.41807500 |
| 182 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.41702266 |
| 183 | mature B cell differentiation (GO:0002335) | 2.40849307 |
| 184 | defense response to protozoan (GO:0042832) | 2.40347832 |
| 185 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.40125766 |
| 186 | positive regulation of mast cell degranulation (GO:0043306) | 2.40125766 |
| 187 | genitalia morphogenesis (GO:0035112) | 2.38717859 |
| 188 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.38701004 |
| 189 | transcytosis (GO:0045056) | 2.38665650 |
| 190 | leukocyte mediated immunity (GO:0002443) | 2.38597695 |
| 191 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.38579429 |
| 192 | anterograde synaptic vesicle transport (GO:0048490) | 2.38370617 |
| 193 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.38215466 |
| 194 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.37981234 |
| 195 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37229283 |
| 196 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.37118163 |
| 197 | response to interferon-alpha (GO:0035455) | 2.36957310 |
| 198 | T cell migration (GO:0072678) | 2.36795565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.27127775 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32133844 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.67263734 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22591623 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83445184 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.80958515 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.53220609 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.29059723 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22434940 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09232989 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.07494639 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04091623 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00784052 |
| 14 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.94071858 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.89210513 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.79600184 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.70273046 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60495520 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.56309432 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53423094 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.53001140 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45066676 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.44936006 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23619506 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17365554 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14005705 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.12821107 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12139889 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09618607 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04994646 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.99975301 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.95676895 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88667296 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87412148 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85662377 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.84765058 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79341318 |
| 38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73906093 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69509543 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68644416 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66807429 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.62794172 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61772630 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.61733131 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61588117 |
| 46 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59989193 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59696741 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56383808 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56317052 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.56189819 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52887107 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52846556 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52259255 |
| 54 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50732851 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49643539 |
| 56 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.49342246 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.49181626 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.48510583 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.48246757 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47942453 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47036390 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.44360381 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.44360381 |
| 64 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42942951 |
| 65 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41770836 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40598689 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40395014 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40387495 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40003352 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39716584 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39648050 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39410677 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36362393 |
| 74 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.35758267 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34596065 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33984583 |
| 77 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33615205 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31663119 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30254949 |
| 80 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29662392 |
| 81 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28757204 |
| 82 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28706437 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28238685 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27724291 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27180236 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26787905 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26747098 |
| 88 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26538760 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26382859 |
| 90 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.25610785 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25363890 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23784912 |
| 93 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23124840 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.23065035 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22340169 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22328507 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21041636 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.20869258 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20296370 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20283631 |
| 101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17661418 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16217602 |
| 103 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16074443 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15912653 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15912653 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.15758852 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15691183 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13211535 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10230553 |
| 110 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09974079 |
| 111 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09781620 |
| 112 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09613025 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09497011 |
| 114 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.09442747 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08226254 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08025893 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06744809 |
| 118 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06315543 |
| 119 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.06010786 |
| 120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05934316 |
| 121 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.05761902 |
| 122 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05488333 |
| 123 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05488333 |
| 124 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04555658 |
| 125 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03365261 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03280178 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02810690 |
| 128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02744978 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00108110 |
| 130 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99781211 |
| 131 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97321716 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97109664 |
| 133 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.97100898 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97032780 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97032780 |
| 136 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94636808 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92353730 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91791733 |
| 139 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90404737 |
| 140 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89741708 |
| 141 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89422463 |
| 142 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88405698 |
| 143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87430897 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86055609 |
| 145 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84182488 |
| 146 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83354143 |
| 147 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.82606709 |
| 148 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82041397 |
| 149 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.81946734 |
| 150 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81637526 |
| 151 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81103977 |
| 152 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81080219 |
| 153 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80453437 |
| 154 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.80364901 |
| 155 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80178950 |
| 156 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78745914 |
| 157 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.77331988 |
| 158 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.76697305 |
| 159 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76557213 |
| 160 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76170491 |
| 161 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75991217 |
| 162 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75702912 |
| 163 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75702912 |
| 164 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75305035 |
| 165 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74543000 |
| 166 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.74353697 |
| 167 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74268656 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73587011 |
| 169 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.72903269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 4.57898404 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.86836020 |
| 3 | MP0002102_abnormal_ear_morphology | 3.42256646 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.33441708 |
| 5 | MP0008057_abnormal_DNA_replication | 3.31544328 |
| 6 | MP0003195_calcinosis | 3.15027337 |
| 7 | MP0003436_decreased_susceptibility_to | 3.13018024 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.12267511 |
| 9 | MP0003303_peritoneal_inflammation | 3.12180051 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.74180964 |
| 11 | MP0009785_altered_susceptibility_to | 2.74041502 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.72930808 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.72312309 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.68443691 |
| 15 | MP0002419_abnormal_innate_immunity | 2.53256486 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.45590679 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.44321850 |
| 18 | MP0005671_abnormal_response_to | 2.41512452 |
| 19 | MP0000685_abnormal_immune_system | 2.38581274 |
| 20 | MP0001790_abnormal_immune_system | 2.30869656 |
| 21 | MP0005387_immune_system_phenotype | 2.30869656 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.21846346 |
| 23 | MP0005025_abnormal_response_to | 2.19977413 |
| 24 | MP0003724_increased_susceptibility_to | 2.16484657 |
| 25 | MP0003136_yellow_coat_color | 2.15299321 |
| 26 | MP0005670_abnormal_white_adipose | 2.09004891 |
| 27 | MP0008058_abnormal_DNA_repair | 2.07282632 |
| 28 | MP0001819_abnormal_immune_cell | 2.06295370 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.04810733 |
| 30 | MP0002723_abnormal_immune_serum | 2.04278551 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.99352280 |
| 32 | MP0001800_abnormal_humoral_immune | 1.96578261 |
| 33 | MP0002006_tumorigenesis | 1.94324793 |
| 34 | MP0004510_myositis | 1.90195962 |
| 35 | MP0005171_absent_coat_pigmentation | 1.89931520 |
| 36 | MP0002938_white_spotting | 1.89712491 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.88621892 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.86066063 |
| 39 | MP0001188_hyperpigmentation | 1.80073400 |
| 40 | MP0003880_abnormal_central_pattern | 1.78623489 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.75052106 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.74211580 |
| 43 | MP0006082_CNS_inflammation | 1.70029218 |
| 44 | MP0003786_premature_aging | 1.69769840 |
| 45 | MP0002009_preneoplasia | 1.68658770 |
| 46 | MP0001324_abnormal_eye_pigmentation | 1.66697944 |
| 47 | MP0001853_heart_inflammation | 1.62786252 |
| 48 | MP0002095_abnormal_skin_pigmentation | 1.62219750 |
| 49 | MP0003448_altered_tumor_morphology | 1.60421325 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.60359354 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.60087935 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.57731969 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.55923119 |
| 54 | MP0003878_abnormal_ear_physiology | 1.55752148 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.55752148 |
| 56 | MP0005310_abnormal_salivary_gland | 1.55697519 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.52832437 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.48187965 |
| 59 | MP0003718_maternal_effect | 1.47509905 |
| 60 | MP0002090_abnormal_vision | 1.47038112 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 1.46224654 |
| 62 | MP0000516_abnormal_urinary_system | 1.46224654 |
| 63 | MP0000716_abnormal_immune_system | 1.44680557 |
| 64 | MP0000858_altered_metastatic_potential | 1.43233243 |
| 65 | MP0002398_abnormal_bone_marrow | 1.42935432 |
| 66 | MP0002163_abnormal_gland_morphology | 1.38843740 |
| 67 | MP0005409_darkened_coat_color | 1.38724757 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.38556575 |
| 69 | MP0002405_respiratory_system_inflammati | 1.37544549 |
| 70 | MP0000613_abnormal_salivary_gland | 1.36859018 |
| 71 | MP0003186_abnormal_redox_activity | 1.35700707 |
| 72 | MP0006292_abnormal_olfactory_placode | 1.33599646 |
| 73 | MP0000647_abnormal_sebaceous_gland | 1.30252171 |
| 74 | MP0002282_abnormal_trachea_morphology | 1.28358762 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.27003920 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.26718487 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.26183220 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 1.24991792 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.22694191 |
| 80 | MP0000427_abnormal_hair_cycle | 1.22614638 |
| 81 | MP0003828_pulmonary_edema | 1.20820014 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.20783056 |
| 83 | MP0004484_altered_response_of | 1.18258725 |
| 84 | MP0003646_muscle_fatigue | 1.18028746 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.16402211 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.15557681 |
| 87 | MP0005253_abnormal_eye_physiology | 1.15347068 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.14536284 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.13502081 |
| 90 | MP0000490_abnormal_crypts_of | 1.11187678 |
| 91 | MP0002429_abnormal_blood_cell | 1.08582375 |
| 92 | MP0000343_altered_response_to | 1.07026350 |
| 93 | MP0008872_abnormal_physiological_respon | 1.05202214 |
| 94 | MP0002722_abnormal_immune_system | 1.03816673 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 1.03434012 |
| 96 | MP0000371_diluted_coat_color | 1.01415573 |
| 97 | MP0005187_abnormal_penis_morphology | 1.00348169 |
| 98 | MP0001545_abnormal_hematopoietic_system | 1.00279880 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 1.00279880 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.99584737 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.97994291 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.95932962 |
| 103 | MP0003075_altered_response_to | 0.95102863 |
| 104 | MP0004859_abnormal_synaptic_plasticity | 0.93936052 |
| 105 | MP0005395_other_phenotype | 0.92389599 |
| 106 | MP0008260_abnormal_autophagy | 0.91726423 |
| 107 | MP0005390_skeleton_phenotype | 0.91296042 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.89878080 |
| 109 | MP0003091_abnormal_cell_migration | 0.89591311 |
| 110 | MP0009764_decreased_sensitivity_to | 0.87083686 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.86546072 |
| 112 | MP0004381_abnormal_hair_follicle | 0.86504911 |
| 113 | MP0004947_skin_inflammation | 0.86313297 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.86135307 |
| 115 | MP0002933_joint_inflammation | 0.85477378 |
| 116 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84789409 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.84659874 |
| 118 | MP0003077_abnormal_cell_cycle | 0.84031488 |
| 119 | MP0002254_reproductive_system_inflammat | 0.82761929 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.81885848 |
| 121 | MP0001186_pigmentation_phenotype | 0.81524372 |
| 122 | MP0005410_abnormal_fertilization | 0.80888016 |
| 123 | MP0008469_abnormal_protein_level | 0.79975083 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.79518084 |
| 125 | MP0008007_abnormal_cellular_replicative | 0.79482337 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.75295696 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.74568130 |
| 128 | MP0002396_abnormal_hematopoietic_system | 0.72984357 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.72280386 |
| 130 | MP0003941_abnormal_skin_development | 0.69646458 |
| 131 | MP0004085_abnormal_heartbeat | 0.69406993 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.69386722 |
| 133 | MP0000749_muscle_degeneration | 0.69234022 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.67595412 |
| 135 | MP0002168_other_aberrant_phenotype | 0.67161829 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.66890497 |
| 137 | MP0004147_increased_porphyrin_level | 0.66833897 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.66156852 |
| 139 | MP0005408_hypopigmentation | 0.66149922 |
| 140 | MP0005379_endocrine/exocrine_gland_phen | 0.65013104 |
| 141 | MP0009840_abnormal_foam_cell | 0.64731962 |
| 142 | MP0010352_gastrointestinal_tract_polyps | 0.64508521 |
| 143 | MP0002177_abnormal_outer_ear | 0.63251008 |
| 144 | MP0009697_abnormal_copulation | 0.63041894 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.62394109 |
| 146 | MP0001851_eye_inflammation | 0.62365302 |
| 147 | MP0003111_abnormal_nucleus_morphology | 0.62032739 |
| 148 | MP0001984_abnormal_olfaction | 0.61740871 |
| 149 | MP0010307_abnormal_tumor_latency | 0.61083816 |
| 150 | MP0003787_abnormal_imprinting | 0.60535300 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.60184120 |
| 152 | MP0005164_abnormal_response_to | 0.59485630 |
| 153 | MP0000604_amyloidosis | 0.59185073 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.58388863 |
| 155 | MP0005220_abnormal_exocrine_pancreas | 0.58111100 |
| 156 | MP0008995_early_reproductive_senescence | 0.57982274 |
| 157 | MP0005166_decreased_susceptibility_to | 0.57524267 |
| 158 | MP0009745_abnormal_behavioral_response | 0.57447817 |
| 159 | MP0001929_abnormal_gametogenesis | 0.56876105 |
| 160 | MP0001529_abnormal_vocalization | 0.56831517 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.56433890 |
| 162 | MP0003755_abnormal_palate_morphology | 0.55961649 |
| 163 | MP0005647_abnormal_sex_gland | 0.55788704 |
| 164 | MP0001119_abnormal_female_reproductive | 0.52507278 |
| 165 | MP0003937_abnormal_limbs/digits/tail_de | 0.52334843 |
| 166 | MP0004133_heterotaxia | 0.51582769 |
| 167 | MP0001756_abnormal_urination | 0.51062993 |
| 168 | MP0005083_abnormal_biliary_tract | 0.50792462 |
| 169 | MP0005332_abnormal_amino_acid | 0.49800126 |
| 170 | MP0008873_increased_physiological_sensi | 0.49734455 |
| 171 | MP0004215_abnormal_myocardial_fiber | 0.49591119 |
| 172 | MP0003656_abnormal_erythrocyte_physiolo | 0.48511161 |
| 173 | MP0004019_abnormal_vitamin_homeostasis | 0.47242524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.95629804 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.25661283 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.17437867 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 4.55367106 |
| 5 | Hypoplasia of the fovea (HP:0007750) | 4.27002721 |
| 6 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.27002721 |
| 7 | Myositis (HP:0100614) | 4.15130607 |
| 8 | Obstructive lung disease (HP:0006536) | 4.11152195 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.11152195 |
| 10 | Stomatitis (HP:0010280) | 4.05864143 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.99075281 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.98665448 |
| 13 | Optic neuritis (HP:0100653) | 3.98665448 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.97457660 |
| 15 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.85649067 |
| 16 | Orchitis (HP:0100796) | 3.66854914 |
| 17 | Abnormality of the fovea (HP:0000493) | 3.62325106 |
| 18 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.54787518 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.41368806 |
| 20 | Intestinal atresia (HP:0011100) | 3.40284161 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.35190500 |
| 22 | Neoplasm of the adrenal cortex (HP:0100641) | 3.35160412 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32247288 |
| 24 | White forelock (HP:0002211) | 3.10102139 |
| 25 | Prostate neoplasm (HP:0100787) | 3.09155195 |
| 26 | Meningitis (HP:0001287) | 3.03965289 |
| 27 | Recurrent skin infections (HP:0001581) | 3.03690793 |
| 28 | Generalized hypopigmentation (HP:0007513) | 3.02875547 |
| 29 | Breast carcinoma (HP:0003002) | 3.02431039 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.01271198 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.99295961 |
| 32 | Follicular hyperkeratosis (HP:0007502) | 2.93870486 |
| 33 | Abnormal auditory evoked potentials (HP:0006958) | 2.92628856 |
| 34 | Gingivitis (HP:0000230) | 2.91809118 |
| 35 | Decreased central vision (HP:0007663) | 2.85812562 |
| 36 | Increased IgM level (HP:0003496) | 2.82848654 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 2.80014132 |
| 38 | Basal ganglia calcification (HP:0002135) | 2.76398911 |
| 39 | Agnosia (HP:0010524) | 2.76031512 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.68723055 |
| 41 | Sensory axonal neuropathy (HP:0003390) | 2.68472334 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66486523 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64817206 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.64504023 |
| 45 | Periodontitis (HP:0000704) | 2.64268695 |
| 46 | Alopecia of scalp (HP:0002293) | 2.62513322 |
| 47 | Vasculitis (HP:0002633) | 2.61750050 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.60888778 |
| 49 | Blue irides (HP:0000635) | 2.60422882 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.60056703 |
| 51 | Cellulitis (HP:0100658) | 2.57312892 |
| 52 | True hermaphroditism (HP:0010459) | 2.50199943 |
| 53 | Absent frontal sinuses (HP:0002688) | 2.49914042 |
| 54 | Thick nail (HP:0001805) | 2.48876867 |
| 55 | Hypothermia (HP:0002045) | 2.47239063 |
| 56 | Abnormality of the columella (HP:0009929) | 2.46067481 |
| 57 | Leukocytosis (HP:0001974) | 2.45821122 |
| 58 | Sparse eyelashes (HP:0000653) | 2.43727988 |
| 59 | Neoplasm of the adrenal gland (HP:0100631) | 2.43666118 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.39334493 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37330374 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37330374 |
| 63 | Chronic otitis media (HP:0000389) | 2.35290109 |
| 64 | Vascular calcification (HP:0004934) | 2.34921226 |
| 65 | Progressive inability to walk (HP:0002505) | 2.31108991 |
| 66 | Acute encephalopathy (HP:0006846) | 2.30663879 |
| 67 | Eosinophilia (HP:0001880) | 2.30630846 |
| 68 | Recurrent viral infections (HP:0004429) | 2.30276727 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 2.27466016 |
| 70 | Generalized hypopigmentation of hair (HP:0011358) | 2.27190555 |
| 71 | Stenosis of the external auditory canal (HP:0000402) | 2.26485569 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.26047306 |
| 73 | Pancreatic cysts (HP:0001737) | 2.24957654 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.23955269 |
| 75 | Ocular albinism (HP:0001107) | 2.23921154 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.22035299 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.21258066 |
| 78 | Stomach cancer (HP:0012126) | 2.20387128 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.19921189 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.18740614 |
| 81 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.17255208 |
| 82 | Disinhibition (HP:0000734) | 2.16302833 |
| 83 | Arterial thrombosis (HP:0004420) | 2.15630598 |
| 84 | Heterochromia iridis (HP:0001100) | 2.12818513 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12685542 |
| 86 | Glomerulopathy (HP:0100820) | 2.12603439 |
| 87 | Increased CSF lactate (HP:0002490) | 2.12195913 |
| 88 | Abnormality of dental color (HP:0011073) | 2.11837373 |
| 89 | Osteomyelitis (HP:0002754) | 2.10168715 |
| 90 | Hypoproteinemia (HP:0003075) | 2.09932307 |
| 91 | Thyroiditis (HP:0100646) | 2.09233067 |
| 92 | Granulocytopenia (HP:0001913) | 2.08411363 |
| 93 | Cutaneous melanoma (HP:0012056) | 2.07679107 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 2.07283696 |
| 95 | Hemoptysis (HP:0002105) | 2.06071755 |
| 96 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05697648 |
| 97 | Thrombocytosis (HP:0001894) | 2.04534678 |
| 98 | Volvulus (HP:0002580) | 2.03619445 |
| 99 | Abnormality of macular pigmentation (HP:0008002) | 2.02699844 |
| 100 | Syringomyelia (HP:0003396) | 2.02164740 |
| 101 | Spinal cord lesions (HP:0100561) | 2.02164740 |
| 102 | Hamartoma of the eye (HP:0010568) | 2.01382580 |
| 103 | Abnormality of chromosome stability (HP:0003220) | 2.00526582 |
| 104 | Freckling (HP:0001480) | 1.99269867 |
| 105 | Iris hypopigmentation (HP:0007730) | 1.99238376 |
| 106 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98884679 |
| 107 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98487047 |
| 108 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.96200513 |
| 109 | Molar tooth sign on MRI (HP:0002419) | 1.96122357 |
| 110 | Abnormality of midbrain morphology (HP:0002418) | 1.96122357 |
| 111 | Cardiovascular calcification (HP:0011915) | 1.95957594 |
| 112 | Obstructive sleep apnea (HP:0002870) | 1.95370736 |
| 113 | Abnormality of methionine metabolism (HP:0010901) | 1.95323545 |
| 114 | Disproportionate short-trunk short stature (HP:0003521) | 1.95143137 |
| 115 | Agammaglobulinemia (HP:0004432) | 1.94704398 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.94346747 |
| 117 | Exertional dyspnea (HP:0002875) | 1.93796959 |
| 118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93608819 |
| 119 | Dyschromatopsia (HP:0007641) | 1.93546549 |
| 120 | Abnormality of the frontal sinuses (HP:0002687) | 1.93019786 |
| 121 | Tongue fasciculations (HP:0001308) | 1.92878988 |
| 122 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92392197 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.91784865 |
| 124 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.90613005 |
| 125 | Focal motor seizures (HP:0011153) | 1.90227992 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89827911 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89827911 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89827911 |
| 129 | Pustule (HP:0200039) | 1.88630234 |
| 130 | Sepsis (HP:0100806) | 1.88023389 |
| 131 | Pulmonary artery stenosis (HP:0004415) | 1.87838240 |
| 132 | Pulmonary fibrosis (HP:0002206) | 1.87553653 |
| 133 | Abnormality of eosinophils (HP:0001879) | 1.87534496 |
| 134 | Methylmalonic acidemia (HP:0002912) | 1.87426301 |
| 135 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.83788543 |
| 136 | Anhidrosis (HP:0000970) | 1.83434629 |
| 137 | Albinism (HP:0001022) | 1.82576029 |
| 138 | Adrenal hypoplasia (HP:0000835) | 1.81090581 |
| 139 | Melanoma (HP:0002861) | 1.81023485 |
| 140 | Hematochezia (HP:0002573) | 1.80295068 |
| 141 | Subacute progressive viral hepatitis (HP:0006572) | 1.79765690 |
| 142 | Inappropriate behavior (HP:0000719) | 1.78123615 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.78029061 |
| 144 | Petechiae (HP:0000967) | 1.77911542 |
| 145 | Porencephaly (HP:0002132) | 1.77852429 |
| 146 | Posterior subcapsular cataract (HP:0007787) | 1.77425394 |
| 147 | Urticaria (HP:0001025) | 1.77361988 |
| 148 | Abnormality of male internal genitalia (HP:0000022) | 1.77322670 |
| 149 | Chest pain (HP:0100749) | 1.76251375 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.75307162 |
| 151 | Patchy hypopigmentation of hair (HP:0011365) | 1.74383752 |
| 152 | Encephalitis (HP:0002383) | 1.74079091 |
| 153 | Gastrointestinal infarctions (HP:0005244) | 1.73861412 |
| 154 | Gastrointestinal atresia (HP:0002589) | 1.72749141 |
| 155 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72001731 |
| 156 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72001731 |
| 157 | Abnormal protein glycosylation (HP:0012346) | 1.72001731 |
| 158 | Abnormal glycosylation (HP:0012345) | 1.72001731 |
| 159 | Pancreatic fibrosis (HP:0100732) | 1.71910583 |
| 160 | Axonal loss (HP:0003447) | 1.71743096 |
| 161 | Microretrognathia (HP:0000308) | 1.71603215 |
| 162 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71443608 |
| 163 | Abnormality of renal resorption (HP:0011038) | 1.70815404 |
| 164 | Meckel diverticulum (HP:0002245) | 1.70692275 |
| 165 | Abnormality of the ileum (HP:0001549) | 1.69956085 |
| 166 | Prolonged bleeding time (HP:0003010) | 1.67613437 |
| 167 | Median cleft lip (HP:0000161) | 1.67283229 |
| 168 | Abnormal lung lobation (HP:0002101) | 1.67155425 |
| 169 | Hypoplastic iliac wings (HP:0002866) | 1.67139456 |
| 170 | Abnormality of the nasal septum (HP:0000419) | 1.67110698 |
| 171 | Conjunctival hamartoma (HP:0100780) | 1.66885248 |
| 172 | Fair hair (HP:0002286) | 1.66597483 |
| 173 | Abnormality of the duodenum (HP:0002246) | 1.66579652 |
| 174 | Atonic seizures (HP:0010819) | 1.66511027 |
| 175 | Bifid tongue (HP:0010297) | 1.66500766 |
| 176 | Abnormality of the preputium (HP:0100587) | 1.66409065 |
| 177 | Diminished motivation (HP:0000745) | 1.66391690 |
| 178 | Abnormality of the renal cortex (HP:0011035) | 1.66242096 |
| 179 | Abnormality of glycolysis (HP:0004366) | 1.65556148 |
| 180 | Clubbing of toes (HP:0100760) | 1.64920016 |
| 181 | Hypokinesia (HP:0002375) | 1.64264617 |
| 182 | Medial flaring of the eyebrow (HP:0010747) | 1.63759719 |
| 183 | Ependymoma (HP:0002888) | 1.62645944 |
| 184 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.61857859 |
| 185 | Metaphyseal dysplasia (HP:0100255) | 1.59585442 |
| 186 | Astigmatism (HP:0000483) | 1.59230831 |
| 187 | Abnormality of the anterior horn cell (HP:0006802) | 1.59229839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 4.31188135 |
| 2 | RIPK4 | 3.90906577 |
| 3 | MAP3K14 | 3.79007305 |
| 4 | WEE1 | 3.70643781 |
| 5 | FRK | 3.39770363 |
| 6 | BRSK2 | 3.37987957 |
| 7 | IRAK4 | 3.30038003 |
| 8 | MKNK2 | 3.17660845 |
| 9 | EIF2AK3 | 2.75462794 |
| 10 | BMPR2 | 2.56183307 |
| 11 | CASK | 2.49757691 |
| 12 | BLK | 2.45002265 |
| 13 | ACVR1B | 2.44187426 |
| 14 | PIM2 | 2.42036079 |
| 15 | TNIK | 2.39254837 |
| 16 | MKNK1 | 2.35212859 |
| 17 | IRAK3 | 2.31219803 |
| 18 | IKBKB | 2.27010051 |
| 19 | FES | 2.23804497 |
| 20 | EIF2AK1 | 2.23203839 |
| 21 | WNK3 | 2.19295285 |
| 22 | GRK1 | 2.16474134 |
| 23 | NUAK1 | 2.12080602 |
| 24 | BCR | 1.87030228 |
| 25 | IKBKE | 1.85737470 |
| 26 | TBK1 | 1.82495397 |
| 27 | MAP3K12 | 1.80391181 |
| 28 | EIF2AK2 | 1.80175397 |
| 29 | NLK | 1.60953882 |
| 30 | MAP3K13 | 1.60903819 |
| 31 | NME2 | 1.56252512 |
| 32 | TXK | 1.54883781 |
| 33 | PLK3 | 1.54842532 |
| 34 | FER | 1.54621909 |
| 35 | JAK3 | 1.53895659 |
| 36 | CHUK | 1.53368589 |
| 37 | KIT | 1.52219732 |
| 38 | CAMKK2 | 1.49673409 |
| 39 | PRPF4B | 1.49320321 |
| 40 | BUB1 | 1.48877730 |
| 41 | YES1 | 1.45455789 |
| 42 | EPHA2 | 1.45004893 |
| 43 | STK39 | 1.44995381 |
| 44 | STK3 | 1.44667091 |
| 45 | STK38L | 1.43394022 |
| 46 | PLK2 | 1.39799309 |
| 47 | PDK2 | 1.38991178 |
| 48 | TYK2 | 1.35581826 |
| 49 | TEC | 1.34198586 |
| 50 | MAP2K7 | 1.33673025 |
| 51 | SIK3 | 1.32131503 |
| 52 | STK10 | 1.30468955 |
| 53 | BRSK1 | 1.30012349 |
| 54 | PIM1 | 1.19556970 |
| 55 | SYK | 1.16486335 |
| 56 | PAK3 | 1.15947027 |
| 57 | EPHA4 | 1.14768277 |
| 58 | ERBB3 | 1.14636051 |
| 59 | CLK1 | 1.13268202 |
| 60 | OXSR1 | 1.11287436 |
| 61 | IRAK1 | 1.06186446 |
| 62 | MUSK | 1.02702414 |
| 63 | TGFBR2 | 1.02119784 |
| 64 | MAP4K2 | 1.01777612 |
| 65 | CDK19 | 0.99421508 |
| 66 | HCK | 0.98477747 |
| 67 | VRK2 | 0.95308969 |
| 68 | NEK9 | 0.94267094 |
| 69 | TLK1 | 0.92616458 |
| 70 | CSNK1G1 | 0.91292604 |
| 71 | SGK2 | 0.90807334 |
| 72 | LYN | 0.90050985 |
| 73 | ERBB4 | 0.89778995 |
| 74 | FGR | 0.89265941 |
| 75 | TAF1 | 0.88531043 |
| 76 | GRK7 | 0.87804321 |
| 77 | MST4 | 0.86992998 |
| 78 | ADRBK2 | 0.86889500 |
| 79 | CSF1R | 0.85926133 |
| 80 | CSNK1G3 | 0.85556900 |
| 81 | ABL2 | 0.82133245 |
| 82 | ARAF | 0.81230109 |
| 83 | PRKCI | 0.80764756 |
| 84 | DAPK1 | 0.79482186 |
| 85 | JAK1 | 0.78968792 |
| 86 | IRAK2 | 0.78854292 |
| 87 | LCK | 0.76736922 |
| 88 | CSNK1G2 | 0.75897166 |
| 89 | CSNK1A1L | 0.75426000 |
| 90 | ZAK | 0.72649588 |
| 91 | ADRBK1 | 0.69628998 |
| 92 | GRK5 | 0.67693008 |
| 93 | PLK4 | 0.67675522 |
| 94 | BCKDK | 0.67405580 |
| 95 | TSSK6 | 0.66425554 |
| 96 | SIK2 | 0.65856710 |
| 97 | BTK | 0.64741286 |
| 98 | FGFR2 | 0.64689007 |
| 99 | MAP4K1 | 0.64462134 |
| 100 | TGFBR1 | 0.62188629 |
| 101 | CSK | 0.61684824 |
| 102 | ZAP70 | 0.61111408 |
| 103 | MAP3K3 | 0.60839146 |
| 104 | PLK1 | 0.60561776 |
| 105 | BMX | 0.60377025 |
| 106 | EPHA3 | 0.59379634 |
| 107 | TESK2 | 0.58463850 |
| 108 | MAPK13 | 0.57734459 |
| 109 | PRKCD | 0.57485117 |
| 110 | CAMKK1 | 0.56624290 |
| 111 | STK24 | 0.54600807 |
| 112 | MAP3K1 | 0.53099040 |
| 113 | TAOK2 | 0.52411734 |
| 114 | MOS | 0.50919637 |
| 115 | CCNB1 | 0.50909373 |
| 116 | FGFR3 | 0.50508316 |
| 117 | PBK | 0.50083380 |
| 118 | INSRR | 0.49937860 |
| 119 | ABL1 | 0.48660303 |
| 120 | TESK1 | 0.45778021 |
| 121 | DYRK3 | 0.45652786 |
| 122 | MAP3K11 | 0.44812332 |
| 123 | RPS6KA4 | 0.44416231 |
| 124 | DMPK | 0.44276715 |
| 125 | STK4 | 0.43661353 |
| 126 | MELK | 0.43017773 |
| 127 | PRKCG | 0.42831541 |
| 128 | DAPK3 | 0.42476260 |
| 129 | MYLK | 0.42451969 |
| 130 | BMPR1B | 0.41895850 |
| 131 | ROCK1 | 0.40667984 |
| 132 | PINK1 | 0.39740940 |
| 133 | MINK1 | 0.39641749 |
| 134 | PRKCE | 0.39320015 |
| 135 | SGK3 | 0.39096467 |
| 136 | VRK1 | 0.38876479 |
| 137 | TAOK3 | 0.38520839 |
| 138 | RAF1 | 0.37803066 |
| 139 | NTRK3 | 0.37704369 |
| 140 | MAP3K5 | 0.37567917 |
| 141 | MST1R | 0.36389637 |
| 142 | SCYL2 | 0.35099708 |
| 143 | NEK1 | 0.34921613 |
| 144 | FGFR1 | 0.34725050 |
| 145 | JAK2 | 0.33757364 |
| 146 | MARK3 | 0.33696125 |
| 147 | RPS6KA6 | 0.33262547 |
| 148 | EGFR | 0.32998628 |
| 149 | LMTK2 | 0.32661321 |
| 150 | PRKCQ | 0.31567226 |
| 151 | MAPKAPK2 | 0.31313512 |
| 152 | CDK6 | 0.31089501 |
| 153 | TTK | 0.31011864 |
| 154 | ATM | 0.30675871 |
| 155 | PIK3CA | 0.30324134 |
| 156 | SRPK1 | 0.30191976 |
| 157 | PTK2B | 0.29980502 |
| 158 | DAPK2 | 0.29308989 |
| 159 | TRPM7 | 0.29177389 |
| 160 | GRK6 | 0.28531920 |
| 161 | IGF1R | 0.28167186 |
| 162 | TIE1 | 0.28053186 |
| 163 | MAP2K1 | 0.25852562 |
| 164 | CSNK2A1 | 0.25354223 |
| 165 | PAK4 | 0.25333811 |
| 166 | CSNK1A1 | 0.23465279 |
| 167 | PRKAA2 | 0.22974454 |
| 168 | STK38 | 0.22860921 |
| 169 | KSR1 | 0.22683912 |
| 170 | CSNK1D | 0.22311474 |
| 171 | ATR | 0.20488211 |
| 172 | WNK4 | 0.20365123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.01358431 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.29503626 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.44274587 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41116156 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39652205 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.33946684 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.30489414 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30178620 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28419396 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18342508 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.05015390 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.97113839 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88765794 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86307503 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.85447527 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83830720 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80208560 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78207432 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77757927 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71931191 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.68681137 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65251075 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.65109177 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.63872280 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59584059 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54025582 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50595289 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.50302441 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.46742506 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46134616 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44808399 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.44412565 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.43110124 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.41877878 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38683497 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36858303 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35505638 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.35075655 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34702677 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34659486 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34634244 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34323444 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33936470 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.32166089 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31743338 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30915768 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.30641187 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28718611 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26943429 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.26384691 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.25653762 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23221165 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21012352 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20252890 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.19123413 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 1.18126179 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17854158 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17346858 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16643757 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16319857 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16130825 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15866170 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15358413 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13710748 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 1.12040681 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 1.09717088 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07905981 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07503791 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.07493868 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07279771 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06461037 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04687250 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04260254 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03295458 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00717152 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96091464 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96084089 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95807786 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.95643859 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.95606367 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95574194 |
| 82 | RNA transport_Homo sapiens_hsa03013 | 0.93921375 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93159367 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91662246 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91157168 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89483635 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89414179 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88855464 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88094446 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87638397 |
| 91 | Cell cycle_Homo sapiens_hsa04110 | 0.87217857 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87117680 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84704441 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83855196 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83381076 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82929346 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78018709 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76860521 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73608619 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72604000 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72377666 |
| 102 | Ribosome_Homo sapiens_hsa03010 | 0.71439391 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71435138 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71078498 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70760003 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70361705 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69968188 |
| 108 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67330051 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.65608078 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65261225 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65033352 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64740743 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.64213672 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63897716 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63679451 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63279861 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62735561 |
| 118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61770204 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.60620808 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.59970880 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59844995 |
| 122 | DNA replication_Homo sapiens_hsa03030 | 0.58436857 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57464189 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57264259 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.56646222 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56056715 |
| 127 | Long-term depression_Homo sapiens_hsa04730 | 0.55675835 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54197751 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54003820 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53452701 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53396452 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53112490 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.52963959 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52857782 |
| 135 | Morphine addiction_Homo sapiens_hsa05032 | 0.52434366 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52245200 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52181963 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51615358 |
| 139 | Proteasome_Homo sapiens_hsa03050 | 0.50858152 |
| 140 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50720116 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50318183 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.50241971 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50218992 |
| 144 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50058041 |
| 145 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49987866 |
| 146 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49913545 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.49568059 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49404499 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48662531 |
| 150 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48541053 |
| 151 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46909133 |
| 152 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45531010 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45032377 |
| 154 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44077516 |
| 155 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43612320 |
| 156 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43545268 |
| 157 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43535462 |
| 158 | Melanoma_Homo sapiens_hsa05218 | 0.43141464 |
| 159 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42872668 |
| 160 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42076907 |
| 161 | Renin secretion_Homo sapiens_hsa04924 | 0.41768669 |
| 162 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41514376 |
| 163 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41062554 |
| 164 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40227370 |
| 165 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39682017 |
| 166 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39118806 |
| 167 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38295521 |
| 168 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37263017 |
| 169 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36563067 |
| 170 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36393514 |
| 171 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35919323 |
| 172 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31825175 |
| 173 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31196140 |
| 174 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31109520 |
| 175 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30899890 |
| 176 | Prostate cancer_Homo sapiens_hsa05215 | 0.29579185 |
| 177 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28425941 |

